Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H20N2O8S2.2Na |
Molecular Weight | 622.577 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].CC1=CC=C(NC2=CC=C(NC3=C(C=C(C)C=C3)S([O-])(=O)=O)C4=C2C(=O)C5=CC=CC=C5C4=O)C(=C1)S([O-])(=O)=O
InChI
InChIKey=FPAYXBWMYIMERV-UHFFFAOYSA-L
InChI=1S/C28H22N2O8S2.2Na/c1-15-7-9-19(23(13-15)39(33,34)35)29-21-11-12-22(30-20-10-8-16(2)14-24(20)40(36,37)38)26-25(21)27(31)17-5-3-4-6-18(17)28(26)32;;/h3-14,29-30H,1-2H3,(H,33,34,35)(H,36,37,38);;/q;2*+1/p-2
DescriptionCurator's Comment: description was created based on several sources, including
https://www.drugs.com/inactive/d-c-green-no-5-354.html | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=74.2205 | https://www.ncbi.nlm.nih.gov/pubmed/25145135 | https://www.ncbi.nlm.nih.gov/pubmed/1697740 | https://www.ncbi.nlm.nih.gov/pubmed/2038271
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/inactive/d-c-green-no-5-354.html | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=74.2205 | https://www.ncbi.nlm.nih.gov/pubmed/25145135 | https://www.ncbi.nlm.nih.gov/pubmed/1697740 | https://www.ncbi.nlm.nih.gov/pubmed/2038271
D&C Green No. 5 is an FDA-approved, synthetic dye produced from petroleum or coal tar sources, that used in pharmaceuticals and cosmetics. D&C Green No. 5 may be safely used for coloring drugs and surgical sutures. In cosmetics, it can be used externally and in general cosmetics, including lipsticks, and cosmetics close to the eye.
Approval Year
Sample Use Guides
The 13 week oral toxicity study in rats revealed a NOEL of 100 mg/kg bw/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1697740
D&C Green No. 5 activity was evaluated against human immunodeficiency virus type 1 (HIV-1) in primary human lymphocytes. The antiviral assays were conducted in mitogen stimulated human PBMC infected with HIV-1 (strain LAV). Stock solutions of the drugs were prepared in DMSO and diluted so that the final concentration of DMSO in the medium did not exceed 0.05%. The D&C Green No. 5 were added about 45 min after infection. Six days later when virus production was at a maximum, the supernatant was clarified and the virus concentrated by high speed centrifugation. The reverse transcriptase activity associated with the disrupted virus was determined. The virus infected control had about 3 x 105 decompositions per minute per ml of reverse transcriptase activity. The blank and uninfected cell control values were about 500 and 1200 dpm, respectively
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C461
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
||
|
CFR |
21 CFR 74.1205
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
||
|
CFR |
21 CFR 74.2205
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1514
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
8J6RDU8L9X
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
8005
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
C024537
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
41838
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
1311171
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
224-546-6
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
DTXSID2024903
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
4403-90-1
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
7795
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
8J6RDU8L9X
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
C71647
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY | |||
|
20431
Created by
admin on Fri Dec 15 15:42:50 GMT 2023 , Edited by admin on Fri Dec 15 15:42:50 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD